PM2.5-Induced Programmed Myocardial Cell Death via mPTP Opening Results in Deteriorated Cardiac Function in HFpEF

Tingting Wu1,2, Minghui Tong2, Aiai Chu3

  • 1The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, China.

Insights

Particulate matter (PM2.5) exposure worsens heart failure by causing cardiomyocyte necrosis via mitochondrial damage. This study reveals PM2.5 opens mitochondrial pores, leading to cell death and impaired heart function in a mouse model.

Area of Science:

  • Environmental Health
  • Cardiovascular Biology
  • Toxicology

Background:

  • Particulate matter (PM2.5) is linked to heart failure exacerbation and mortality, but mechanisms are unclear.
  • Heart failure with preserved ejection fraction (HFpEF) is a growing concern, with PM2.5 potentially worsening outcomes.
  • Understanding PM2.5's cellular impact is crucial for developing targeted interventions.

Purpose of the Study:

  • To investigate the mechanisms by which PM2.5 induces cardiomyocyte programmed necrosis.
  • To determine PM2.5's role in cardiac function impairment in a mouse model of HFpEF.
  • To explore the involvement of mitochondrial pathways and specific protein interactions.

Main Methods:

  • HFpEF mice were exposed to concentrated ambient PM2.5 (CAP) or filtered air (FA) for 6 weeks.
  • In vitro studies assessed oxidative stress, mitochondrial permeability transition pore (mPTP) dynamics, and cell death in H9C2 cells.
  • Co-immunoprecipitation identified interactions between p53 and cyclophilin D (CypD).

Main Results:

  • CAP exposure impaired cardiac function in HFpEF mice.
  • PM2.5 induced mitochondrial damage, necrosis in cardiomyocytes, increased reactive oxygen species (ROS), DNA damage, and decreased mitochondrial membrane potential.
  • A p53/CypD interaction was observed, and inhibiting CypD reversed PM2.5-induced cell death.

Conclusions:

  • PM2.5 triggers cardiomyocyte programmed necrosis by opening the mPTP.
  • This mitochondrial-mediated necrosis may exacerbate cardiac dysfunction in HFpEF.
  • Targeting the p53/CypD pathway and mPTP could be a therapeutic strategy.

Related Concept Videos